|
German Shepherd KC DNA bundle (DM Exon2+F8+MDR1+CIM)
Test number: 8708
Price: £ 144.00 (including VAT) for all 4 tests
|
update |
Congenital Idiopathic Megaesophagus (CIM) has now been added to this bundle
|
|
|
|
|
|
|
1 ) Degenerative Myelopathy / Degenerative Radiculomyelopathy) DM (Exon 2) / SOD1
|
Breeds
|
Airedale Terrier
,
Alaskan Malamute
,
All Dog Breeds
,
American Eskimo
,
Bernese Mountain Dog
,
Bloodhound
,
Borzoi (Russian Wolfhound)
,
Boxer
,
Cavalier King Charles Spaniel
,
Canaan Dog
,
Welsh Corgi (Cardigan)
,
Chesapeake Bay Retriever
,
Cockapoo (English)
,
Cockapoo (American)
,
Fox Terrier
,
French Bull Dog
,
German Shepherd
,
Glen Of Imaal Terrier ( GIT )
,
Golden Retriever
,
Goldendoodle
,
Pyrenean Mountain Dog (Great Pyrenees)
,
Hovawart
,
Pumi ( Hungarian Pumi / Pumik )
,
Jack Russell Terrier
,
Kerry Blue Terrier
,
Labradoodle
,
Labrador Retriever
,
Lakeland Terrier
,
Northern Inuit (Tamaskan / British Timber Dog)
,
Nova Scotia Duck tolling Retriever ( NSDTR / Toller)
,
Pembroke Welsh Corgi
,
Poodle
,
Pug
,
Rhodesian Ridgeback
,
Rough Collie
,
Soft Coated Wheaten Terrier
,
Shetland Sheepdog (Sheltie)
,
Smooth Collie
,
Utonagan
,
Wire Fox Terrier
.
|
|
|
Kennel Club
|
This test is part of the Official UK Kennel Club DNA Testing Scheme in Chesapeake Bay Retriever, French Bull Dog, German Shepherd, Nova Scotia Duck tolling Retriever ( NSDTR / Toller), Rough Collie, and Smooth Collie.
for UK registered dogs, Laboklin can send results of the tests which are part of the Official UK Kennel Club DNA testing scheme to the Kennel Club (KC) to be recorded and published
as part of the Kennel Club scheme. Results will only be recorded and published by the KC if the result report includes the dog’s
microchip or tattoo number along with either the dog’s registered name or registered number. Any test results that do not carry these identifying
features will not be recorded by the Kennel Club.
In order to ensure that test results are sent to the Kennel Club, customers must also sign the declaration section on the order form to give Laboklin permission to do so.
important:
When you sign the declaration, Laboklin will send the results to the KC on your behalf, and you do not need to send them to the KC yourself again to avoid unnecessary duplications.
|
|
|
The Disease |
Canine degenerative myelopathy (also known as chronic degenerative radiculomyelopathy) is a progressive disease of the spinal cord in older dogs. The disease has an insidious onset typically between 7 and 14 years of age. It begins with a loss of coordination (ataxia) in the hind limbs. As of July 15, 2008 the mutated gene responsible for DM has been found present in 43 breeds including German Shepherds, Boxers, Chesapeake Bay Retrievers, Rhodesian Ridgebacks, and both breeds of Welsh Corgis. The disease is chronic and progressive, and resulting in paralysis.
|
|
|
|
Clinical Signs |
Degenerative myelopathy initially affects the back legs and causes muscle weakness and loss, and lack of coordination. These cause a staggering effect that may appear to be arthritis. The dog may drag one or both rear paws when it walks. This dragging can cause the nails of one foot to be worn down. The condition may lead to extensive paralysis of the back legs. As the disease progresses, the animal may display symptoms such as incontinence and has considerable difficulties with both balance and walking. If allowed to progress, the animal will show front limb involvement and extensive muscle atrophy. Eventually cranial nerve or respiratory muscle involvement necessitates euthanasia.
Progression of the disease is generally slow but highly variable. The animal could be crippled within a few months, or may survive up to three years
|
|
|
|
Trait of Inheritance |
Tow alleles are invloved in Degenerative Myelopathy, A and G, therefore a test result can be A/A, A/G, or G/G.
Mode of inheritance is autosomal recessive with variable penetrance;
|
Inheritance : AUTOSOMAL
RECESSIVE
trait
Sire
|
|
Dam
|
|
Offspring
|
|
|
|
|
|
clear
|
|
clear
|
|
100% clear
|
|
|
|
|
|
clear
|
|
carrier
|
|
50% clear + 50%
carriers
|
|
|
|
|
|
clear
|
|
affected
|
|
100% carriers
|
|
|
|
|
|
carrier
|
|
clear
|
|
50% clear + 50%
carriers
|
|
|
|
|
|
carrier
|
|
carrier
|
|
25% clear + 25% affected
+ 50% carriers
|
|
|
|
|
|
carrier
|
|
affected
|
|
50% carriers + 50%
affected
|
|
|
|
|
|
affected
|
|
clear
|
|
100% carriers
|
|
|
|
|
|
affected
|
|
carrier
|
|
50% carriers + 50%
affected
|
|
|
|
|
|
affected
|
|
affected
|
|
100% affected
|
Clear
Genotype: N / N [ Homozygous normal ]
The dog is noncarrier of the mutant gene.
It is very unlikely that the dog will show signs of the Degenerative Myelopathy
Carrier
Genotype: N / DM (Exon 2) [ Heterozygous ]
The dog carries one copy of the mutant gene and one
copy of the normal gene.
It is very unlikely that the dog will show signs of the Degenerative Myelopathy
Affected
Genotype: DM (Exon 2) / DM (Exon 2) [ Homozygous mutant ]
The dog carries two copies of the mutant gene and
therefore it will pass the mutant gene to its entire offspring.
The dog may or may not show signs of the disease
|
|
|
|
|
2 ) Haemophilia A (factor VIII deficiency / F8)
|
Breeds
|
Boxer
,
German Shepherd
,
Labrador Retriever
,
Old English Sheepdog (Bobtail)
,
Rhodesian Ridgeback
.
|
|
|
The Disease |
Haemophilia A is one of the most important inherited disorders of haemostasis in Havanese Dogs. The underlying pathomechanism of Haemophilia A is a lack or decreased activity of factor VIII that plays a critical role in the coagulation cascade. Affected dogs present with hemorrhage that can vary from mild to severe depending on the degree of the disease. The clinical signs include haematomas of large sizes, bleeding of the nose, skin, muscles and joints. If the disease is severe and no precautions are taken, affected dogs can bleed to death after surgery or injury.
In cooperation with Prof. Dr. Mischke (Tierärztliche Hochschule Hannover) LABOKLIN was able to identify a SINE insert in exon 14 of the factor VIII gene that is responsible for the lack of active factor VIII protein in Havanese Dogs.
Haemophilia A is a sex-linked disorder (x-chromosomal recessive). Male dogs express the disease when they have one mutated x-chromosome. The mutated x-chromosome comes from the bitch. In most cases female dogs are carrier of one mutated x-chromosome without being diseased (conductor). According to Mendel's Law of Inheritance, 50% of the male puppies of a carrier bitch will have the mutated x-chromosome and express the disease and 50% of the female puppies will be healthy carriers (conductors). Female dogs will be diseased when they have two mutated x-chromosomes (one from the mother, one from the father). In that case both, father and mother must have the mutated x-chromosome (e.g. diseased male dog bred to conductor bitch).
|
|
|
|
Description |
DNA test
The mutation responsible for haemophilia A can now be identified using our DNA-test. The test can be performed on dogs of any age and even puppies can be tested. The DNA test does not only differentiate healthy and diseased dogs, but furthermore identifies healthy carrier (female) dogs. This is of crucial importance for dog breeders.
To achieve a maximum reliability of the test result, we perform the DNA-test of each submitted sample in two independent test runs.
|
|
|
|
Trait of Inheritance |
There are 3 possible genotypes:
1. Homozygous healthy:
Genotype female: N(X)/N(X),
Genotype male: N(X)/Y (homozygous healthy)
A dog like this is healthy and does not carry the mutated x-chromosome. Offspring of this dog will not get the mutated x-chromosome.
2. Heterozygous carrier (only female):
Genotype female: N(X)/FVIII(X) (heterozygous carrier)
A bitch like this carries one copy of the mutated gene. It is unlikely that the bitch will suffer from haemophilia A, however there is a 50% chance that she will pass on the mutation to her offspring.
3. Homozygous affected:
Genotype female FVIII(X)/FVIII(X) (homozygous affected)
Genotype male FVIII(X)/Y (hemizygous affected)
Because of the x-chromosomal mode of inheritance, a homozygous affected female dog carries two mutated x-chromosomes and a hemizygous affected male dog carries one mutated x-chromosome. Female and male affected dogs have a high risk to express haemophilia A. The bitch will pass on the mutation to a 100% of her offspring and 50% of the offspring of the male dog will get the mutated x-chromosome.
|
Inheritance : X-LINKED
RECESSIVE
trait
Sire |
|
Dam |
|
Offspring |
|
|
|
|
Males |
|
Females |
clear
|
|
clear
|
|
100% clear
|
|
100% clear
|
|
|
|
|
|
|
|
clear
|
|
carrier
|
|
50% clear + 50%
affected
|
|
50% clear + 50%
carriers
|
|
|
|
|
|
|
|
clear
|
|
affected
|
|
100% affected
|
|
100% carriers
|
|
|
|
|
|
|
|
affected
|
|
clear
|
|
100% clear
|
|
100% carriers
|
|
|
|
|
|
|
|
affected
|
|
carrier
|
|
50% affected + 50% clear
|
|
50% affected + 50%
carriers
|
|
|
|
|
|
|
|
affected
|
|
affected
|
|
100% affected
|
|
100% affected
|
Male:
Clear
Genotype: N [ normal ]
The dog is noncarrier of the mutant gene.
The dog will never develop Haemophilia A (factor VIII deficiency / F8) and therefore it can be used in breeding and should only be bred to clear females.
Affected
Genotype: FVIII [ mutant ]
The dog carries the mutant gene and will pass it its entire female offspring.
The dog will develop Haemophilia A (factor VIII deficiency / F8) and will pass the mutant gene to its entire female offspring
Female:
Clear
Genotype: N / N [ Homozygous normal ]
The dog is noncarrier of the mutant gene.
The dog will never develop Haemophilia A (factor VIII deficiency / F8) and therefore it can be used in breeding and should only be bred to clear females.
Carrier
Genotype: N / FVIII [ Heterozygous ]
The dog carries one copy of the mutant gene and one
copy of the normal gene.
The dog will never develop Haemophilia A (factor VIII deficiency / F8) but since it carries the mutant gene, it can pass it on to its offspring.
Affected
Genotype: FVIII / FVIII [ Homozygous mutant ]
The dog carries two copies of the mutant gene and
therefore it will pass the mutant gene to its entire offspring.
The dog will develop Haemophilia A (factor VIII deficiency / F8) and will pass the mutant gene to its entire female offspring
|
|
|
|
|
3 ) MDR1 Gene Varian / Ivermectin Sensitivity * (ABCB1)
|
Breeds
|
American White Shepherd
,
Australian Shepherd
,
Bobtail
,
Border Collie
,
Collie
,
Elo
,
English shepherd
,
German Shepherd
,
Kromfohrländer
,
Longhaired Whippet
,
McNab Shepherd (McNab Border Collie)
,
Miniature American Shepherd
,
Old English Sheepdog (Bobtail)
,
Rough Collie
,
Shetland Sheepdog (Sheltie)
,
Silken Windhound
,
Smooth Collie
,
Waeller (Wäller)
,
White Swiss Shepherd ( Berger Blanc Suisse )
.
|
|
|
Kennel Club
|
This test is part of the Official UK Kennel Club DNA Testing Scheme in Australian Shepherd, Border Collie, Rough Collie, Shetland Sheepdog (Sheltie), and Smooth Collie.
for UK registered dogs, Laboklin can send results of the tests which are part of the Official UK Kennel Club DNA testing scheme to the Kennel Club (KC) to be recorded and published
as part of the Kennel Club scheme. Results will only be recorded and published by the KC if the result report includes the dog’s
microchip or tattoo number along with either the dog’s registered name or registered number. Any test results that do not carry these identifying
features will not be recorded by the Kennel Club.
In order to ensure that test results are sent to the Kennel Club, customers must also sign the declaration section on the order form to give Laboklin permission to do so.
important:
When you sign the declaration, Laboklin will send the results to the KC on your behalf, and you do not need to send them to the KC yourself again to avoid unnecessary duplications.
|
|
|
The Disease |
MDR1 is a genetic disorder found in many dog breeds. Affected dogs, when treated with certain common drugs such as Ivermectin and loperamide (Imodium), are unable to pump out these drugs from the brain resulting in poisoning and neurologic symptoms ranging from tremors, anorexia and excess salivation to blindness, coma and even death. Some of these drugs such as Ivermectins, which vets prescribe extensively for the treatment of parasite infections, are able to cause toxicity at 1/200th of the dose required to cause toxicity in healthy dogs.
Scientists discovered that these dogs lack a protein (P-Glycoprotein), which is responsible for pumping out many drugs and toxins from the brain, and that affected dogs show signs of toxicity because they are unable to stop drugs from permeating their brains. Researchers have identified that this condition is due to a mutation in the multi-drug resistance gene [MDR1].
LIST OF DRUGS THAT CAUSE SENSITIVITY TO DOGS WITH MDR1 MUTATION
Class A |
Do not use these drugs in dogs with MDR1 Gene Defect |
Ivermectine substances "Anti parasites": (Diapec®, Ecomectin®, Equimax®, Eqvalan®, Ivomec®, Noromectin®, Paramectin®, Qualimec®, Sumex®, Virbamec®)
Doramectine substances "Anti parasites": (Dectomax® )
Loperamide substances "ant diarrheal ":
(Imodium®)
Moxidectine substances "Anti Parasites" (Cydectin®, Equest®) |
Class B |
Use only under close control of veterinarian |
Cytostatics "Chemotherapy": (Vinblastine, Vincristine, Doxorubicine, Paclitaxel, Docetaxel, Methotrexat, Vincristine)
Immunosuppressive: (Cyclosporine A)
Heart glycosides: (Digoxine, Methyldigoxine)
Opioids: (Morphium)
Antiarrhythmics: (Verapamil, Diltiazem, Chinidine)
Antiemetics (Ondansetron, Domperidon, Metoclopramide )
Antibiotics (Sparfloxacin, Grepafloxacin, Erythromycin)
Antihistamin (Ebastin)
Glucocorticoid (Dexamethason)
Acepromazine (tranquilizer and pre-anesthetic agent) *
Butorphanol "analgesic and pre-anesthetic agent" *
Other drugs:
Etoposide, Mitoxantrone, Ondansetron, Paclitaxel, Rifampicin |
Class C |
Can be used only in the permitted application form and dose! |
Selamectin (Stronghold®), Milbemax® and Advocate® . |
* In dogs with the MDR1 mutation, acepromazine and butorphanol tend to cause more profound and prolonged sedation in dogs . It is recommended to reduce the dose by 25% in dogs heterozygous for the MDR1 mutation (MDR1 / N) and by 30-50% in dogs homozygous for the MDR1 mutation (MDR1 / MDR1).
|
|
|
|
|
Description |
This is a mutation-based gene test, which offers many advantages over other methods
The MDR1 gene variant can be detected, using molecular genetic testing techniques. By DNA testing the mutation can be shown directly. The testing is carried out by state of the art laboratory methods and therefore provides a very high accuracy. In general DNA tests can be done at any age. These tests identify both affected and carrier animals. The mutation can be shown directly, what clearly identifies homozygous affected animals. The genetic test offers the unique possibility to identify Ivermectin sensitive animals prior to treatment with Ivermectin and other drugs (see list). * partner lab
Please note drug list may not be up to date. The WSU Veterinary CLinical Pharmacology Lab may have a more updated list https://vcpl.vetmed.wsu.edu/problem-drugs. Please note that there maybe other problem drugs which may have not been yet identified.
|
|
|
|
Trait of Inheritance |
Dogs that are homozygous for the mutation display, due to a non-functional transporter the ivermectin sensitive phenotype. They can show increased absorption of ivermectin and other substrates e.g. Digoxin, Vincristine, Doxorubicin, Cyclosporin A, Grepafloxacin, Dexamethasone and Loperamide (See list of drugs). Heterozygous animals (carriers) may show sensitivity to avermectins and other drugs. They are able to propagate the responsible mutation throughout the population and it is therefore important that carrier animals are detected prior to breeding. Carriers mayhave sensitivity and should be treated with care
|
Inheritance : AUTOSOMAL
trait
|
|
|
|
|
|
|
4 ) Congenital Idiopathic Megaesophagus (CIM)
|
|
Description |
German shepherd dogs (GSDs) are predisposed to an inherited motility disorder of the esophagus (the gullet), termed congenital idiopathic megaesophagus (CIM), in which the esophagus is enlarged and swallowing is ineffective. Affected puppies are unable to properly pass food into their stomachs and consequently regurgitate their meals and show a failure to thrive, often leading to euthanasia.
The disease affects males more than females which is thought to be due to the estrogen protection role in females.
Congenital Idiopathic Megaesophagus (CIM) is thought to be caused by a mutation in teh gene which encodes a receptor for melanin-concentrating hormone, a signaling molecule that is linked to appetite, weight, and gut motility.
The disease affects males more than females which is thought to be due to the estrogen protection role in females.
Congenital Idiopathic Megaesophagus (CIM) is thought to be caused by a variant in the gene which encodes a receptor for melanin-concentrating hormone, a signaling molecule that is linked to appetite, weight, and gut motility.
This is a high-risk factor variant and so dogs with the variant have higher risk of developing the disease.
The single-copy allele (N/CIM) is strongly associated with CIM, with homozygosity (CIM/CIM) for this allele posing the most significant risk.
both sex and the variant can predict affection status in over 75% of dogs , and a genetic test is now available at Laboklin to facilitate breeding decisions aimed at reducing disease incidence.
|
|
|
|
Trait of Inheritance |
Complex mode of inheritance
|
Inheritance :
trait
|
|
|
|
|
Price
for the above 4 tests
|
£ 144.00 (including VAT)
|
|
|
|
|
|
|